Characteristics and Safety Assessment of Intractable Proteins in Genetically Modified Crops

Bushey D, Bannon G, Delaney B, Graser G, Hefford M, Jiang X, Lee T, Madduri K, Pariza M, Privalle L, Ranjan R, Saab-Rincon G, Schafer B, Thelen J, Zhang J, Harper M
Regulatory Toxicology and Pharmacology
July 31, 2014

DOI: 10.1016/j.yrtph.2014.03.003

Abstract: Genetically modified (GM) crops may contain newly expressed proteins that are described as “intractable”. Safety assessment of these proteins may require some adaptations to the current assessment procedures. Intractable proteins are defined here as those proteins with properties that make it extremely difficult or impossible with current methods to express in heterologous systems; isolate, purify, or concentrate; quantify (due to low levels); demonstrate biological activity; or prove equivalency with plant proteins. Five classes of intractable proteins are discussed here: (1) membrane proteins, (2) signaling proteins, (3) transcription factors, (4) N-glycosylated proteins, and (5) resistance proteins (R-proteins, plant pathogen recognition proteins that activate innate immune responses). While the basic tiered weight-of-evidence approach for assessing the safety of GM crops proposed by the International Life Sciences Institute (ILSI) in 2008 is applicable to intractable proteins, new or modified methods may be required. For example, the first two steps in Tier I (hazard identification) analysis, gathering of applicable history of safe use (HOSU) information and bioinformatics analysis, do not require protein isolation. The extremely low level of expression of most intractable proteins should be taken into account while assessing safety of the intractable protein in GM crops. If Tier II (hazard characterization) analyses requiring animal feeding are judged to be necessary, alternatives to feeding high doses of pure protein may be needed. These alternatives are discussed here.

Download the journal article here.